Novavax, Inc.’s filing revealed that its Director YOUNG JAMES F unloaded Company’s shares for reported $0.11 million on Jun 21 ’24. In the deal valued at $14.09 per share,7,500 shares were sold. As a result of this transaction, YOUNG JAMES F now holds 61,760 shares worth roughly $0.84 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, YOUNG JAMES F sold 7,500 shares, generating $102,881 in total proceeds. Upon selling the shares at $13.72, the Director now owns 69,260 shares.
Before that, Dubovsky Filip sold 13,904 shares. Novavax, Inc. shares valued at $201,164 were divested by the President, R&D at a price of $14.47 per share. As a result of the transaction, Dubovsky Filip now holds 66,613 shares, worth roughly $0.91 million.
JP Morgan downgraded its Novavax, Inc. [NVAX] rating to an Underweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in early May from “an Underweight” to “a Neutral”. BofA Securities also remained covering NVAX and has increased its forecast on May 10, 2024 with a “Neutral” recommendation from previously “an Underperform” rating. B. Riley Securities revised its rating on August 09, 2023. It rated NVAX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of NVAX
On Friday, Novavax, Inc. [NASDAQ:NVAX] saw its stock jump 14.18% to $13.61. Over the last five days, the stock has gained 17.02%. Novavax, Inc. shares have risen nearly 183.54% since the year began. Nevertheless, the stocks have risen 84.92% over the past one year. While a 52-week high of $23.86 was reached on 06/06/24, a 52-week low of $3.53 was recorded on 02/05/24. SMA at 50 days reached $12.96, while 200 days put it at $8.63.
Levels Of Support And Resistance For NVAX Stock
The 24-hour chart illustrates a support level at 12.28, which if violated will result in even more drops to 10.94. On the upside, there is a resistance level at 14.49. A further resistance level may holdings at 15.36. The Relative Strength Index (RSI) on the 14-day chart is 57.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.54, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 13.55%. Stochastics %K at 55.74% indicates the stock is a holding.
How much short interest is there in Novavax, Inc.?
A steep rise in short interest was recorded in Novavax, Inc. stocks on 2024-08-30, growing by 2.85 million shares to a total of 31.61 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 28.76 million shares. There was a rise of 9.02%, which implies that there is a positive sentiment for the stock.
